Through genome-wide association studies, it was discovered that ACE2 expression increased in the brain tissue of severely affected Alzheimer’s Disease patients and posed a potential risk for Covid transmission (Ciaccio et al., 2021). This evidence concerns the gene ACE2 and early-onset autosomal dominant Alzheimer disease.